PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsPrednisolone tebutate
Prednisolone tebutate
Blephamide, Cetapred, Chloroptic-p, Cortalone, Delta-cortef, Fernisolone-p, Hydeltra-tba, Meti-derm, Metimyd, Neo-delta-cortef, Neo-hydeltrasol, Pred, Prelone, Sterane, Sulphrin, Sulster, Vasocidin (prednisolone tebutate) is a small molecule pharmaceutical. Prednisolone tebutate was first approved as Chloroptic-p s.o.p. on 1982-01-01. It is used to treat adrenal insufficiency, ankylosing spondylitis, asthma, atopic dermatitis, and berylliosis amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
neoplasmsD009369
musculoskeletal diseasesD009140
digestive system diseasesD004066
respiratory tract diseasesD012140
nervous system diseasesD009422
eye diseasesD005128
urogenital diseasesD000091642
hemic and lymphatic diseasesD006425
hereditary congenital and neonatal diseases and abnormalitiesD009358
Show 7 more
Trade Name
FDA
EMA
Omnipred, Orapred, Pediapred, Pred, Pred mild (generic drugs available since 1982-01-01, discontinued: Cortalone, Delta-cortef, Econopred, Fernisolone-p, Flo-pred, Hydeltra-tba, Hydeltrasol, Inflamase, Inflamase mild, Meti-derm, Meticortelone, Metreton, Predair, Prelone, Sterane)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Gentamicin sulfate
+
Prednisolone acetate
Tradename
Company
Number
Date
Products
PRED-GAllerganN-050586 DISCN1988-06-10
1 products, RLD
PRED-GAllerganN-050612 DISCN1989-12-01
1 products, RLD
Hide discontinued
Neomycin sulfate
+
Polymyxin b sulfate
+
Prednisolone acetate
Tradename
Company
Number
Date
Products
POLY-PREDAllerganN-050081 DISCN1982-01-01
1 products
Hide discontinued
Neomycin sulfate
+
Prednisolone sodium phosphate
Tradename
Company
Number
Date
Products
NEO-HYDELTRASOLMerck KGaAN-050378 DISCN1982-01-01
1 products
Hide discontinued
Prednisolone
Tradename
Company
Number
Date
Products
STERANEMylanN-009996 DISCN1982-01-01
1 products
DELTA-CORTEFPharmacia & UpjohnN-009987 DISCN1982-01-01
1 products
METI-DERMMerck Sharp & DohmeN-010209 DISCN1982-01-01
1 products
Hide discontinued
Prednisolone acetate
Tradename
Company
Number
Date
Products
PRED FORTEAbbVieN-017011 RX1982-01-01
1 products, RLD, RS
PRED MILDAbbVieN-017100 RX1982-01-01
1 products, RLD, RS
OMNIPREDSandozN-017469 RX1982-01-01
1 products, RLD, RS
Show 4 discontinued
Prednisolone acetate
+
Sulfacetamide sodium
Tradename
Company
Number
Date
Products
BLEPHAMIDEAllerganN-012813 DISCN1982-01-01
1 products, RLD
METIMYDMerck Sharp & DohmeN-010210 DISCN1982-01-01
2 products
Hide discontinued
Prednisolone sodium phosphate
Tradename
Company
Number
Date
Products
ORAPRED ODTConcordia LaboratoriesN-021959 RX2006-06-01
3 products, RLD, RS
PEDIAPREDSeton PharmaceuticalsN-019157 RX1986-05-28
1 products, RLD, RS
Show 2 discontinued
Prednisolone sodium phosphate
+
Sulfacetamide sodium
Tradename
Company
Number
Date
Products
VASOCIDINNovartisN-018988 DISCN1988-08-26
1 products, RLD
Hide discontinued
Prednisolone tebutate
Tradename
Company
Number
Date
Products
HYDELTRA-TBAMerck KGaAN-010562 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
pred phos - bromunapproved drug other2018-06-08
pred-bromunapproved drug other2018-03-01
pred-gatiunapproved drug other2018-02-22
pred-gati-bromunapproved drug other2018-02-22
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
adrenal insufficiency—D000309—
ankylosing spondylitisEFO_0003898D013167M45
asthmaEFO_0000270D001249J45
atopic dermatitisEFO_0000274D003876L20
berylliosisEFO_0007168D001607J63.2
brain neoplasmsEFO_0003833D001932C71
collagen diseases—D003095—
conjunctivitis—D003231H10
dermatitis herpetiformis—D003874L13.0
edema—D004487R60.9
Show 19 more
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Prednisolone Acetate, Flo-Pred, Taro
77993312028-10-11DPU-139, U-1068
ATC Codes
A: Alimentary tract and metabolism drugs
— A01: Stomatological preparations
— A01A: Stomatological preparations
— A01AC: Corticosteroids for local oral treatment
— A01AC04: Prednisolone
— A01AC54: Prednisolone, combinations
— A07: Antidiarrheals, intestinal antiinflammatory/antiinfective agents
— A07E: Intestinal antiinflammatory agents
— A07EA: Corticosteroids acting locally
— A07EA01: Prednisolone
C: Cardiovascular system drugs
— C05: Vasoprotectives
— C05A: Agents for treatment of hemorrhoids and anal fissures for topical use
— C05AA: Corticosteroids, topical for treatment of hemorrhoids and anal fissures
— C05AA04: Prednisolone
D: Dermatologicals
— D07: Corticosteroids, dermatological preparations
— D07A: Corticosteroid dermatological preparations, plain
— D07AA: Corticosteroids, weak (group i)
— D07AA03: Prednisolone
— D07B: Corticosteroids, combinations with antiseptics
— D07BA: Corticosteroids, weak, combinations with antiseptics
— D07BA01: Prednisolone and antiseptics
— D07C: Corticosteroids, combinations with antibiotics
— D07CA: Corticosteroids, weak, combinations with antibiotics
— D07CA03: Prednisolone and antibiotics
— D07X: Corticosteroids, other combinations
— D07XA: Corticosteroids, weak, other combinations
— D07XA02: Prednisolone
H: Systemic hormonal preparations, excl. sex hormones and insulins
— H02: Corticosteroids for systemic use
— H02A: Corticosteroids for systemic use, plain
— H02AB: Glucocorticoids, systemic
— H02AB06: Prednisolone
R: Respiratory system drugs
— R01: Nasal preparations
— R01A: Decongestants and other nasal preparations for topical use
— R01AD: Corticosteroid nasal preparations for topical use
— R01AD02: Prednisolone
— R01AD52: Prednisolone, combinations
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01B: Antiinflammatory agents, ophthalmologic
— S01BA: Corticosteroid ophthalmologic antiinflammatory agents, plain
— S01BA04: Prednisolone
— S01BB: Corticosteroids and mydriatics in combination
— S01BB02: Prednisolone and mydriatics
— S01C: Antiinflammatory agents and antiinfectives in combination
— S01CA: Corticosteroids and antiinfectives in combination, opthalmologic
— S01CA02: Prednisolone and antiinfectives
— S01CB: Corticosteroids/antiinfectives/mydriatics in combination
— S01CB02: Prednisolone
— S02: Otologicals
— S02B: Corticosteroid otologicals
— S02BA: Corticosteroids
— S02BA03: Prednisolone
— S02C: Corticosteroids and antiinfectives in combination, otologic
— S02CA: Corticosteroids and antiinfectives in combination
— S02CA01: Prednisolone and antiinfectives
— S03: Ophthalmological and otological preparations
— S03B: Corticosteroid ophthalmologic and otologic preparations
— S03BA: Corticosteroids
— S03BA02: Prednisolone
— S03C: Corticosteroids and antiinfectives in combination, opthalmologic and otologic
— S03CA: Corticosteroids and antiinfectives in combination
— S03CA02: Prednisolone and antiinfectives
V: Various drug classes in atc
— V03: All other therapeutic products
— V03A: All other therapeutic products
— V03AB: Antidotes
— V03AB05: Prednisolone and promethazine
HCPCS
No data
Clinical
Clinical Trials
2079 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223—C85.911382311079
Prostatic neoplasmsD011471—C611039164669
Rheumatoid arthritisD001172EFO_0000685M06.93181516556
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.0823179353
AsthmaD001249EFO_0000270J45259151243
Kidney transplantationD016030——1111217242
Covid-19D000086382—U07.1271651541
Large b-cell lymphoma diffuseD016403—C83.362761—35
Multiple sclerosisD009103EFO_0003885G355777731
Lupus nephritisD008181EFO_0005761——1294429
Show 233 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938—C95124713—870
Graft vs host diseaseD006086—D89.81112811—549
Myelodysplastic syndromesD009190—D469362—446
Non-hodgkin lymphomaD008228—C85.95203—327
Multiple myelomaD009101—C90.0485—118
Plasma cell neoplasmsD054219——392—418
Alcoholic hepatitisD006519EFO_1001345K70.1167—518
Hodgkin diseaseD006689—C812114—117
Hemophagocytic lymphohistiocytosisD051359—D76.1128—414
Myeloid leukemia acuteD015470—C92.06112——14
Show 139 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myeloproliferative disordersD009196—D47.148——213
Myelodysplastic-myeloproliferative diseasesD054437——18——211
Fanconi anemiaD005199Orphanet_84D61.0936——18
NeuroblastomaD009447EFO_0000621—15———6
Ovarian neoplasmsD010051EFO_0003893C56—6———6
MelanomaD008545———4———4
Myelomonocytic leukemia juvenileD054429—C93.323———4
Mantle-cell lymphomaD020522—C83.1—4———4
Digeorge syndromeD004062—D82.121——13
Nasopharyngeal carcinomaD000077274———3———3
Show 136 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Therapeutic equivalencyD013810——3————3
FeverD005334HP_0001945R50.91———12
T-cell lymphomaD016399——1————1
T-cell leukemiaD015458——1————1
SyndromeD013577——1————1
Lymphoid leukemiaD007945—C911————1
Precursor t-cell lymphoblastic leukemia-lymphomaD054218——1————1
Innate immunityD007113——1————1
PharmacokineticsD010599——1————1
Raynaud diseaseD011928EFO_1001145I73.01————1
Show 17 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Critical illnessD016638——————33
Intervertebral disc displacementD007405EFO_1001800—————33
Insulin resistanceD007333HP_0000855E88.819————33
HypertensionD006973EFO_0000537I10————33
Pathologic dilatationD004108——————33
RegenerationD012038——————33
Granulomatous mastitisD058890—N61.2————22
Blood pressureD001794EFO_0004325—————22
VitiligoD014820EFO_0004208L80————22
Failed back surgery syndromeD055111——————22
Show 123 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePrednisolone tebutate
INNprednisolone
Description
Prednisolone tebutate is a corticosteroid hormone.
Classification
Small molecule
Drug classsteroids (not prednisolone derivatives); prednisone and prednisolone derivatives
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
Identifiers
PDB—
CAS-ID7681-14-3
RxCUI—
ChEMBL IDCHEMBL1200909
ChEBI ID8381
PubChem CID93055
DrugBankDB14632
UNII ID9PHQ9Y1OLM (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 88,606 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
108,353 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use